Objective To evaluate the epidemiological trends and patterns of cervical cancer, uterine cancer and ovarian cancer in China in 1990 and 2019. Design Systematical and updated worldwide epidemiological study. Setting Global Burden of Disease (GBD) Study 2019. Population or Sample. Chinese population was obtained from World Health Organization (WHO) World Standard Population Distribution (2000-2025) and the United Nations World Population Prospects 2019 Revision. Methods Data were extracted from the Global Burden of Diseases, Injuries, and Risk Factors Study 2019. GBD methodology was used to estimate the burden of gynecological malignancies in China, including cervical cancer, uterine cancer and ovarian cancer. Main Outcome Measures The incidence, mortality, disability-adjusted life-years (DALYs), and estimated annual percentage change (EAPC) were systematically analyzed. We additionally predicted the incidence and mortality of gynecological malignancies from 2020 to 2030. Results From 1990 to 2019, the numbers of incidence cases, deaths and DALYs of cervical cancer, uterine cancer and ovarian cancer all significantly increased. The EAPCs in age-standardized incidence rate (ASIR) of three cancers were 1.61 (95% CI: 1.35, 1.88), 1.26 (95% CI: 0.58, 1.94) and 1.88 (95% CI: 1.79, 1.98). From 2020 to 2030, the predicted numbers of incident cases and deaths of gynecological malignancies should continue to increase, and the incidences of uterine cancer would expect to exceed cervical cancer in 2030. Conclusions In China, the numbers of new cases and deaths of gynecological malignancies will continue to increase in the next ten years. Reducing the prevalence of gynecological malignancies should be prioritized in future work.